Standout Papers

Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in <i>PIK3CA</i>-Altered So... 2018 2026 2020 2023 289
  1. Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study (2018)
    Dejan Juric, Jordi Rodón et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 25 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Alkene dialkylation by triple radical sorting
2024 StandoutNature
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
2 intermediate papers

Works of Lars Blumenstein being referenced

Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer
2018
Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
2018 Standout

Author Peers

Author Last Decade Papers Cites
Lars Blumenstein 920 289 335 36 1.3k
Yan Ling 1024 122 231 57 1.7k
Vrushank Davé 1085 423 262 33 1.7k
Elena Ardini 1013 326 525 37 1.6k
Kamil Paruch 869 261 602 51 1.7k
Petra Hååg 789 237 183 43 1.2k
Mitsugu Araki 1033 417 387 46 1.4k
Mathew P. Martin 1101 212 492 35 1.6k
Daqing Wu 923 323 460 53 1.6k
Latha Ramdas 1149 93 244 45 1.5k
Janis Liebetanz 966 112 386 11 1.6k

All Works

Loading papers...

Rankless by CCL
2026